Landscapes / Targets
IDO1
3 drugs act on IDO1, in 4 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | — | |||
| Also tested for | Metastatic Melanoma, Unresectable Melanoma and 2 more | ||||
| Open drug page | |||||
— |
Moderna · Public MRNA |
Phase 1/2 | 18 Feb 2032Phase 1/2 trial completes | ||
| Next date | 18 Feb 2032 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 8 Oct 2030Phase 1 trial completes | |||
| Next date | 8 Oct 2030 · Phase 1 trial completes | ||||
| Also tested for | Progressive Pediatric Brain Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026